Urine proteomic profiling of uranium nephrotoxicity

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 6, 2009, Pages 882-891

  Malard, Véronique ^a   Gaillard, Jean Charles ^a   Bérenguer, Frédéric ^a   Sage, Nicole ^a   Quéméneur, Eric ^a  

^a DIF   (France)

Author keywords

Mass spectrometry; Toxicology; Toxicoproteomics; Uranium; Urine

Indexed keywords

ALBUMIN; CERULOPLASMIN; EPIDERMAL GROWTH FACTOR; URANIUM; URANYL NITRATE; VITAMIN D BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOLLOW UP; GLOMERULUS FILTRATION; KIDNEY INJURY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NEPHROTOXICITY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEOMICS; RAT; UNINDEXED SEQUENCE; URINALYSIS; WESTERN BLOTTING;

ANIMALS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; KIDNEY; MALE; PROTEINURIA; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; URANIUM;

ANIMALIA; RATTUS;

EID: 67349279825     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.01.010     Document Type: Article

References (48)

1. Leggett R.W. The behavior and chemical toxicity of U in the kidney: a reassessment. Health Phys. 57 (1989) 365-383
2. Sanchez D.J., Belles M., Albina M.L., Sirvent J.J., and Domingo J.L. Nephrotoxicity of simultaneous exposure to mercury and uranium in comparison to individual effects of these metals in rats. Biol. Trace Elem. Res. 84 (2001) 139-154
3. Sun D.F., Fujigaki Y., Fujimoto T., Goto T., Yonemura K., and Hishida A. Relation of distal nephron changes to proximal tubular damage in uranyl acetate-induced acute renal failure in rats. Am. J. Nephrol. 22 (2002) 405-416
4. Sun D.F., Fujigaki Y., Fujimoto T., Yonemura K., and Hishida A. Possible involvement of myofibroblasts in cellular recovery of uranyl acetate-induced acute renal failure in rats. Am. J. Pathol. 157 (2000) 1321-1335
5. Taulan M., Paquet F., Argiles A., Demaille J., and Romey M.C. Comprehensive analysis of the renal transcriptional response to acute uranyl nitrate exposure. BMC Genomics 7 (2006) 2
6. Craft E., Abu-Qare A., Flaherty M., Garofolo M., Rincavage H., and Abou-Donia M. Depleted and natural uranium: chemistry and toxicological effects. J. Toxicol. Environ. Health, B. Crit. Rev. 7 (2004) 297-317
7. P.H.S. ATSDR - U.S. Department of Health and Human Services, Toxicological profile for uranium - http://www.atsdr.cdc.gov/toxprofiles/tp150.html, Atlanta, GA, 1999.
8. Squibb K.S., Leggett R.W., and McDiarmid M.A. Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel. Health Phys. 89 (2005) 267-273
9. Duarte C.G., and Preuss H.G. Assessment of renal function - glomerular and tubular. Clin. Lab. Med. 13 (1993) 33-52
10. Zamora M.L., Tracy B.L., Zielinski J.M., Meyerhof D.P., and Moss M.A. Chronic ingestion of uranium in drinking water: a study of kidney bioeffects in humans. Toxicol. Sci. 43 (1998) 68-77
11. Rehman I., Azzouzi A.R., Catto J.W., Allen S., Cross S.S., Feeley K., Meuth M., and Hamdy F.C. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology 64 (2004) 1238-1243
12. Celis J.E., Wolf H., and Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis 21 (2000) 2115-2121
13. Theodorescu D., Wittke S., Ross M.M., Walden M., Conaway M., Just I., Mischak H., and Frierson H.F. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 7 (2006) 230-240
14. Cutillas P.R., Chalkley R.J., Hansen K.C., Cramer R., Norden A.G., Waterfield M.D., Burlingame A.L., and Unwin R.J. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am. J. Physiol., Renal. Physiol. 287 (2004) F353-364
15. Zhang Y.F., Wu D.L., Guan M., Liu W.W., Wu Z., Chen Y.M., Zhang W.Z., and Lu Y. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin. Biochem. 37 (2004) 772-779
16. Meier M., Kaiser T., Herrmann A., Knueppel S., Hillmann M., Koester P., Danne T., Haller H., Fliser D., and Mischak H. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J. Diabetes Complicat. 19 (2005) 223-232
17. Wittke S., Haubitz M., Walden M., Rohde F., Schwarz A., Mengel M., Mischak H., Haller H., and Gwinner W. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am. J. Transplant. 5 (2005) 2479-2488
18. Decramer S., Wittke S., Mischak H., Zurbig P., Walden M., Bouissou F., Bascands J.L., and Schanstra J.P. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 12 (2006) 398-400
19. Vlahou A., Schanstra J., Frokiaer J., El Nahas M., Spasovski G., Mischak H., Domon B., Allmaier G., Bongcam-Rudloff E., and Attwood T. Establishment of a European Network for Urine and Kidney Proteomics. J. Proteomics 71 (2008) 490-492
20. Thongboonkerd V., Klein J.B., and Arthur J.M. Proteomic identification of a large complement of rat urinary proteins. Nephron, Exp. Nephrol. 95 (2003) e69-e78
21. Lee R.S., Monigatti F., Lutchman M., Patterson T., Budnik B., Steen J.A., Freeman M.R., and Steen H. Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation. Proteomics 8 (2008) 1097-1112
22. Mueller L.N., Brusniak M.Y., Mani D.R., and Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 7 (2008) 51-61
23. Perkins D.N., Pappin D.J., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
24. Wang Y., Chen Y., Zhang Y., Wu S., Ma S., Hu S., Zhang L., Shao C., Li M., and Gao Y. Differential ConA-enriched urinary proteome in rat experimental glomerular diseases. Biochem. Biophys. Res. Commun. 371 (2008) 385-390
25. Pang J.X., Ginanni N., Dongre A.R., Hefta S.A., and Opitek G.J. Biomarker discovery in urine by proteomics. J. Proteome Res. 1 (2002) 161-169
26. Gao J., Opiteck G.J., Friedrichs M.S., Dongre A.R., and Hefta S.A. Changes in the protein expression of yeast as a function of carbon source. J. Proteome Res. 2 (2003) 643-649
27. Gao J., Friedrichs M.S., Dongre A.R., and Opiteck G.J. Guidelines for the routine application of the peptide hits technique. J. Am. Soc. Mass Spectrom. 16 (2005) 1231-1238
28. Fach E.M., Garulacan L.A., Gao J., Xiao Q., Storm S.M., Dubaquie Y.P., Hefta S.A., and Opiteck G.J. In vitro biomarker discovery for atherosclerosis by proteomics. Mol. Cell Proteomics 3 (2004) 1200-1210
29. Cheng C.W., Rifai A., Ka S.M., Shui H.A., Lin Y.F., Lee W.H., and Chen A. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int. 68 (2005) 2694-2703
30. Belles M., Linares V., Luisa Albina M., Sirvent J., Sanchez D.J., and Domingo J.L. Melatonin reduces uranium-induced nephrotoxicity in rats. J. Pineal Res. 43 (2007) 87-95
31. Adachi J., Kumar C., Zhang Y., Olsen J.V., and Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7 (2006) R80
32. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., and Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8 (2004) R204-R212
33. Ngai H.H., Sit W.H., Jiang P.P., Xu R.J., Wan J.M., and Thongboonkerd V. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J. Proteome Res. 5 (2006) 3038-3047
34. Mao Y., Desmeules M., Schaubel D., Berube D., Dyck R., Brule D., and Thomas B. Inorganic components of drinking water and microalbuminuria. Environ. Res. 71 (1995) 135-140
35. Kurttio P., Auvinen A., Salonen L., Saha H., Pekkanen J., Makelainen I., Vaisanen S.B., Penttila I.M., and Komulainen H. Renal effects of uranium in drinking water. Environ. Health Perspect. 110 (2002) 337-342
36. Meistermann H., Norris J.L., Aerni H.R., Cornett D.S., Friedlein A., Erskine A.R., Augustin A., De Vera Mudry M.C., Ruepp S., Suter L., Langen H., Caprioli R.M., and Ducret A. Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol. Cell Proteomics. 5 (2006) 1876-1886
37. Sharma K., Lee S., Han S., Lee S., Francos B., McCue P., Wassell R., Shaw M.A., and RamachandraRao S.P. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5 (2005) 2648-2655
38. Thongboonkerd V., Klein J.B., Jevans A.W., and McLeish K.R. Urinary proteomics and biomarker discovery for glomerular diseases. Contrib. Nephrol. 141 (2004) 292-307
39. Nouwen E.J., Verstrepen W.A., Buyssens N., Zhu M.Q., and De Broe M.E. Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab. Invest. 70 (1994) 479-493
40. Leonard I., Zanen J., Nonclercq D., Toubeau G., Heuson-Stiennon J.A., Beckers J.F., Falmagne P., Schaudies R.P., and Laurent G. Modification of immunoreactive EGF and EGF receptor after acute tubular necrosis induced by tobramycin or cisplatin. Ren. Fail. 16 (1994) 583-608
41. Toubeau G., Nonclercq D., Zanen J., Laurent G., Schaudies P.R., and Heuson-Stiennon J.A. Renal tissue expression of EGF and EGF receptor after ischaemic tubular injury: an immunohistochemical study. Exp. Nephrol. 2 (1994) 229-239
42. Uchida M., Teranishi H., Aoshima K., Katoh T., Kasuya M., and Inadera H. Elevated urinary levels of vitamin D-binding protein in the inhabitants of a cadmium polluted area, Jinzu River basin, Japan. Tohoku J. Exp. Med. 211 (2007) 269-274
43. Carretero O.A., and Scicli A.G. In: Laragh J.H., and Brenner B.M. (Eds). The kallikrein-kinin system as a regulator of cardiovascular and renal function., vol. (1995), Raven Press, New York 983-999
44. Naicker S., Naidoo S., Ramsaroop R., Moodley D., and Bhoola K. Tissue kallikrein and kinins in renal disease. Immunopharmacology 44 (1999) 183-192
45. Maes M.B., Scharpe S., and De Meester I. Dipeptidyl peptidase II (DPPII), a review. Clin. Chim. Acta 380 (2007) 31-49
46. Vidaud C., Dedieu A., Basset C., Plantevin S., Dany I., Pible O., and Quemeneur E. Screening of human serum proteins for uranium binding. Chem. Res. Toxicol. 18 (2005) 946-953
47. Goudie J., Chandra M., Lawrence G.D., and Williams P. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat. Res. Commun. Chem. Pathol. Pharmacol. 83 (1994) 33-49
48. Berradi H., Bertho J.M., Dudoignon N., Mazur A., Grandcolas L., Baudelin C., Grison S., Voisin P., Gourmelon P., and Dublineau I. Renal anemia induced by chronic ingestion of depleted uranium in rats. Toxicol. Sci. 103 (2008) 397-408